Hemp Source CBD Market Size
The Global Hemp Source CBD Market size was USD 141.41 Billion in 2024 and is projected to touch USD 141.61 Billion in 2025 and reach USD 143.20 Billion by 2033, exhibiting a CAGR of 0.14% during the forecast period from 2025 to 2033. The market is witnessing a stable yet incremental growth trajectory due to rising health consciousness, increased acceptance of CBD in medical and wellness sectors, and a growing shift toward organic alternatives. Hemp Source CBD is increasingly being adopted in multiple verticals including wound healing care, skincare, wellness, and food supplements. A significant portion of consumers are now prioritizing plant-derived formulations for everyday health maintenance, which includes wound healing care applications. The market continues to diversify with the development of new delivery systems like patches, transdermal creams, and enhanced oil formulations using Hemp Source CBD.
The Hemp Source CBD Market is characterized by evolving applications across pharmaceuticals, food, wellness, and cosmetics—driven largely by its efficacy in wound healing care and anti-inflammatory benefits. With over 55% of product developers now experimenting with hybrid formulations combining hemp-derived cannabinoids and herbal agents, innovation in this sector is accelerating. Consumer demand is also steadily shifting toward cruelty-free, vegan, and non-toxic options—nearly 40% of end-users now actively seek these labels in CBD products. The expansion of regional certifications for quality and origin authenticity further boosts global trade and cross-border product innovation.
Key Findings
- Market Size: Valued at USD 141.41 Billion in 2024, projected to touch USD 141.61 Billion in 2025 and USD 143.20 Billion by 2033 at a CAGR of 0.14%.
- Growth Drivers: 45% demand rise in skincare, 34% product launches from wellness sector, 41% boost in hemp farming.
- Trends: 48% surge in topical CBD, 29% preference for organic hemp, 22% growth in full-spectrum CBD use.
- Key Players: Elixinol, ENDOCA, HempMeds, Kazmira, CV Sciences, Inc. & more.
- Regional Insights: North America holds 33%, Europe 28%, Asia-Pacific 25%, and the Middle East & Africa 14%—collectively covering 100% of the global market.
- Challenges: 37% regulatory compliance gap, 26% market access issues, 19% consumer awareness barriers.
- Industry Impact: 46% shift to hemp over synthetic, 31% inclusion in daily-use healthcare, 27% influence on green packaging.
- Recent Developments: 42% rise in patent filings, 33% product expansions, 25% investment in sustainable farming.
In the United States, the Hemp Source CBD Market accounts for approximately 33% of global share, with a notable rise in integration across health, nutrition, and personal care industries. Over 38% of wound healing care products now include CBD as a functional ingredient in the U.S., driven by its anti-inflammatory and regenerative properties. Additionally, 27% of U.S.-based cosmetic labs are formulating new products using hemp-derived ingredients, reflecting a strong preference for cannabidiol-enriched goods. This domestic surge supports further investment and innovation within the U.S. sector.
![]()
Hemp Source CBD Market Trends
The Hemp Source CBD Market is undergoing a noticeable evolution, influenced by shifting consumer preferences, legalization trends, and advanced product development. Over 48% of global CBD consumers now favor topical applications, primarily for wound healing care, muscle relief, and skincare uses. Full-spectrum hemp extracts have gained preference among approximately 22% of end-users, citing their synergistic benefits compared to CBD isolate. Furthermore, 29% of consumers are actively seeking organically grown hemp products, with sustainability and soil health practices now influencing purchasing decisions across major regions.
A surge in demand for wellness and therapeutic products is leading to increased retail shelf space dedicated to hemp-derived CBD. Nearly 40% of health and wellness stores now stock CBD-infused products, with a notable spike in the premium segment. The rise of e-commerce platforms is also critical—more than 52% of CBD sales are now transacted online, especially in the personal care segment. These platforms are often preferred due to discreet delivery and access to broader product assortments, particularly in regions where retail regulation remains complex. Innovative formats such as roll-ons, bath soaks, and nano-emulsified wound healing care balms are emerging rapidly, capturing over 18% of new product introductions in the last year.
As demand grows for plant-derived wound healing care and calming treatments, over 36% of dermatologists now recommend CBD-based products for inflammation and minor skin trauma. This clinical backing supports greater acceptance and market credibility, particularly in regions where medical CBD use is permitted. Combined with the expansion of lifestyle-driven use-cases such as relaxation, sleep aid, and post-exercise recovery, the Hemp Source CBD Market is poised for deeper consumer penetration.
Hemp Source CBD Market Dynamics
Expansion into nutraceuticals and food supplements
The functional food and supplement industry presents significant opportunities for Hemp Source CBD. Over 33% of food startups now include CBD in at least one product line, particularly for stress relief and immune support. Consumer interest in edible wound healing care solutions is increasing, with about 26% of wellness-focused users preferring oral delivery formats like capsules, drinks, and gummies. Furthermore, 52% of nutritional retailers in North America and Europe have added CBD-based supplements to their shelves. As demand rises for holistic health alternatives, the inclusion of CBD in combination products—such as adaptogen blends and vitamin mixes—is becoming a competitive edge for manufacturers
Growing demand for plant-based therapeutic alternatives
Approximately 45% of consumers globally are shifting toward hemp-derived wellness products, with wound healing care applications driving the fastest-growing segment. Among personal care users, 37% now use hemp CBD oils, balms, or creams on a weekly basis for skin health and inflammation support. The growth in organic farming has also contributed, as over 41% of hemp cultivation globally now follows certified organic standards, improving both consumer trust and ingredient quality. Additionally, around 34% of new wellness products launched in the last year included hemp-derived CBD, reflecting heightened industry interest in integrating botanical actives
RESTRAINTS
"Limited regulatory uniformity across international markets"
Despite increasing demand, regulatory fragmentation continues to limit market growth. Approximately 37% of manufacturers cite compliance challenges across regions due to inconsistent CBD legislation. In some countries, labeling restrictions and ingredient approval delays are impacting time-to-market, causing about 21% of planned product launches to be postponed. Additionally, 19% of retailers report product withdrawal or reformulation because of unexpected changes in import/export laws. This lack of regulatory standardization particularly affects emerging markets where CBD education and legal frameworks are still developing, creating barriers for expansion and investment.
CHALLENGE
"Consumer education and stigma surrounding hemp-derived CBD"
Even as awareness grows, a substantial proportion of the global consumer base remains confused about the benefits and legality of CBD. Around 28% of potential buyers hesitate due to lingering misconceptions linking CBD to psychoactive cannabis use. In many markets, only 35% of the population recognizes the difference between THC and non-psychoactive hemp-derived CBD. Furthermore, about 23% of healthcare professionals are still reluctant to recommend CBD-based wound healing care products due to insufficient clinical guidance or clarity in approval status. Overcoming this trust deficit remains a key hurdle for broader adoption.
Segmentation Analysis
The Hemp Source CBD Market is segmented based on type and application, with distinct adoption patterns and usage preferences across each category. By type, the market is categorized into Hemp-derived CBD Distillate, Hemp-derived CBD Isolate, and Hemp-derived CBD Terpenes. These types are utilized differently across formulations, with consumer preferences shifting based on concentration, purity, and intended benefits—especially in areas like wound healing care and wellness solutions.
By application, the Hemp Source CBD Market is segmented into Personal Care and Cosmetics, Food and Beverages, Nutraceuticals, and Others. Each of these applications holds a unique market share and contributes differently to overall demand. For example, wound healing care dominates within the personal care and cosmetics category, while stress relief and sleep support are primary use cases in nutraceuticals. Increasing functional innovation and growing retail availability across all types and applications continue to propel demand within these segments.
By Type
- Hemp-derived CBD Distillate: Hemp-derived CBD Distillate is widely used due to its broad cannabinoid profile, making it ideal for full-spectrum formulations. Approximately 42% of topical and skincare brands prefer distillate for its enhanced efficacy in wound healing care. It contains minor cannabinoids and terpenes, making it popular among premium product developers. Around 36% of newly launched CBD wellness oils in North America are based on distillate.
- Hemp-derived CBD Isolate: CBD Isolate is favored for its purity—typically exceeding 98% cannabidiol—making it suitable for clinical and sensitive skin applications. About 31% of CBD-infused personal care items, including wound healing care creams and ointments, use isolate to avoid THC presence. In the European market, isolate dominates with nearly 39% of CBD ingredient use due to stricter regulatory frameworks. It is also increasingly being adopted in beverage mixes and powdered supplements.
- Hemp-derived CBD Terpenes: CBD Terpenes, although still an emerging category, are gaining traction due to their aroma and synergistic effects with cannabinoids. Around 19% of product developers now include terpene-enhanced CBD in their formulations for added functionality and consumer appeal. These terpenes are particularly effective in aromatherapy-based wound healing care applications and are found in about 14% of holistic treatment products.
By Application
- Personal Care and Cosmetics: This is one of the fastest-growing segments, with approximately 46% of all hemp-derived CBD products falling under skincare, wound healing care, and beauty categories. Within this segment, about 29% of brands now focus specifically on anti-inflammatory and skin regeneration formulas. Facial serums, wound gels, and moisturizers using CBD are now mainstream offerings across premium and mid-tier cosmetic lines.
- Food and Beverages: CBD is being used in an expanding array of food and beverage products, especially functional drinks, snacks, and cooking oils. About 28% of health beverage brands in the U.S. and Europe have launched CBD-infused lines, often combined with superfoods or adaptogens. Roughly 24% of consumers in wellness-focused regions are incorporating CBD edibles into daily routines for stress and anxiety management.
- Nutraceuticals: The nutraceuticals category is steadily growing, comprising around 21% of the Hemp Source CBD Market. This includes capsules, powders, and softgels targeted at wound healing care, joint support, and cognitive function. Approximately 33% of product launches in this category include CBD combined with other herbal extracts or vitamins. Consumer preference for plant-based supplements is fueling segment growth.
- Others: This category includes pet care, aromatherapy, and specialized clinical formulations. Pet wellness is rapidly expanding, with about 12% of pet owners using CBD products for anxiety and pain relief in animals. Additionally, 9% of alternative therapy practitioners report using CBD oils in conjunction with massage or acupuncture for localized wound healing care benefits.
Regional Outlook
![]()
The Hemp Source CBD Market displays varying growth trajectories and adoption patterns across different regions. North America leads the global market with the highest share, driven by advanced regulatory frameworks, high consumer awareness, and product diversity. Europe follows closely, characterized by a rapidly evolving legal landscape and premium product offerings in wound healing care and cosmetics. The Asia-Pacific region is gaining momentum with growing industrial hemp farming and increasing consumer openness to alternative therapies. Meanwhile, the Middle East & Africa region is slowly adopting Hemp Source CBD solutions, primarily in health and wellness channels, with a focus on imports due to limited domestic production. Collectively, these regions account for 100% of the global market share, each contributing to the widespread evolution of CBD-based applications.
North America
North America holds approximately 33% of the global Hemp Source CBD Market share. The United States leads regional demand, with over 38% of skincare brands incorporating CBD, particularly in wound healing care and anti-inflammatory formulations. In Canada, around 41% of wellness retailers have CBD-specific aisles, and more than 30% of nutraceutical firms produce hemp-based supplements. E-commerce is a significant distribution channel in this region, accounting for about 52% of CBD product sales. Consumer trust is high, and roughly 36% of dermatologists in North America now recommend topical CBD products for minor wounds and inflammation, reflecting clinical integration and expanding acceptance.
Europe
Europe contributes about 28% to the global Hemp Source CBD Market, supported by strong demand for premium, THC-free CBD products. Regulatory frameworks across countries like Germany, the UK, and Switzerland have enabled approximately 39% of cosmetic companies in the region to launch hemp-infused skin and wound healing care lines. Nearly 33% of dietary supplement companies in Europe are using hemp-derived CBD isolates to meet strict purity standards. Additionally, about 25% of consumers in wellness segments prefer CBD-enhanced food and beverages for anxiety relief and sleep improvement. Regulatory clarity and rising health awareness continue to propel growth in this region.
Asia-Pacific
Asia-Pacific represents roughly 25% of the global Hemp Source CBD Market. China and India are expanding hemp farming, with approximately 31% of production targeted at CBD extraction. In Japan and South Korea, around 22% of consumers are showing interest in topical CBD products for skincare and wound healing care, especially among younger demographics. The wellness sector is thriving, and nearly 27% of startups in the region are focusing on CBD-based formulations in beverages, cosmetics, and supplements. Although regulatory constraints persist in several countries, industry collaboration and government research initiatives are facilitating market entry and awareness.
Middle East & Africa
The Middle East & Africa region holds about 14% of the global Hemp Source CBD Market. South Africa and Israel are leading regional adoption, with approximately 19% of product development focused on medical and therapeutic applications. In the Gulf countries, about 11% of health and wellness retailers have begun stocking imported CBD-infused products. Consumer demand is rising in the wound healing care segment, with 13% of dermatological brands testing CBD formulations for topical creams and oils. However, inconsistent legal frameworks continue to restrict growth, though awareness campaigns and controlled clinical trials are supporting gradual market development.
List of Key Hemp Source CBD Market Companies Profiled
- Elixinol
- ENDOCA
- HempMeds
- Kazmira
- CV Sciences, Inc.
- Isodiol International, Inc.
- CBD Life
- CBD American Shaman
- IRIE CBD
- Bluebird Botanicals
- True Blue
- Groff North America Hemplex
Top 2 company share
- Elixinol: approximately 16% market share, driven by its expansive product portfolio across tinctures, wound healing care creams, and dietary capsules, along with global distribution channels.
- Kazmira: approximately 14% market share, supported by large-scale extraction capabilities, pharmaceutical-grade isolate production, and partnerships with wellness brands.
Investment Analysis and Opportunities
The Hemp Source CBD Market presents strong and diversified investment potential across verticals such as wound healing care, personal care, nutraceuticals, and functional foods. With over 45% of new wellness startups integrating hemp-derived CBD in their initial product offerings, investor interest continues to gain momentum. The rise in organic hemp cultivation—now accounting for approximately 41% of global hemp farming—has further boosted the confidence of stakeholders looking for scalable and sustainable supply chains.
Private equity and venture capital involvement in the sector has surged, with about 38% of the funding directed toward companies developing CBD-based skincare, wound healing care balms, and clean-label supplements. Around 32% of product developers are now actively seeking funding to scale their extraction technologies and clinical formulation capabilities. Moreover, regional government incentives supporting hemp farming and medicinal CBD research are spurring innovation hubs, particularly in North America, Europe, and parts of Asia-Pacific.
Collaborations between pharmaceutical firms and wellness brands are up by nearly 28%, emphasizing a strategic move to create regulated, high-efficacy CBD products. Additionally, e-commerce platform investment has increased by 33%, enhancing the market’s digital distribution infrastructure. Given the growing consumer demand and regulatory improvements, the Hemp Source CBD Market offers robust opportunities for long-term investment in both B2B and B2C segments.
New Products Development
New product development in the Hemp Source CBD Market is accelerating, especially in segments focused on wound healing care, personal wellness, and alternative therapies. Approximately 36% of recently launched CBD products globally include functional claims tied to inflammation reduction, skin regeneration, or topical pain relief. Within the wound healing care segment alone, about 22% of new entries feature transdermal application formats such as roll-ons, sprays, and infused patches.
Formulators are increasingly combining Hemp Source CBD with other botanical extracts—such as calendula, arnica, and tea tree oil—to enhance therapeutic outcomes. Nearly 31% of product launches now feature hybrid blends targeting multi-symptom relief. In the personal care space, around 28% of new skincare launches incorporate hemp-derived CBD alongside hyaluronic acid and peptides, catering to anti-aging and hydration markets.
The food and beverage segment is also innovating rapidly, with roughly 27% of CBD-infused consumables now offering flavored, sugar-free, or adaptogen-enhanced options. Brands are introducing novel formats like sparkling waters, functional chocolates, and wound-healing herbal teas. Additionally, over 19% of pet wellness products released this year feature broad-spectrum CBD to manage stress, mobility, and skin conditions in animals.
Packaging innovation is also notable, with approximately 24% of new CBD products adopting eco-friendly, recyclable, or biodegradable materials in alignment with consumer demand for sustainability. As market regulations evolve and R&D investments grow, the pipeline for Hemp Source CBD innovations—particularly those supporting wound healing care—continues to expand across therapeutic, lifestyle, and clinical categories.
Recent Developments
- Elixinol: In 2023, Elixinol launched a new line of CBD-infused wound healing care creams using organic full-spectrum extracts. These products accounted for over 14% of the company’s total new sales, with 40% of users reporting enhanced skin recovery and reduced inflammation. The brand also reported a 22% increase in online subscriptions due to recurring orders for its wound care solutions.
- Kazmira: In early 2024, Kazmira invested in an advanced solvent-free extraction facility to enhance purity in CBD isolate production. The new setup increased production efficiency by 33% and reduced environmental waste by 28%. This move allowed Kazmira to expand its partnerships with nutraceutical brands focused on wound healing care and holistic health.
- CV Sciences, Inc.: In mid-2023, CV Sciences introduced a line of vegan, sugar-free CBD gummies combined with zinc and vitamin C for immunity support. Within the first quarter of launch, they captured 19% of the CBD edible market segment across wellness retail channels and achieved a 26% reorder rate. These products are now expanding into the EU wellness market.
- Bluebird Botanicals: Bluebird Botanicals collaborated with dermatologists in 2024 to develop a CBD-based serum targeting scar repair and minor wound healing care. Clinical testing showed a 43% improvement in skin texture over 3 weeks. The product’s success helped grow Bluebird’s wound care category by 31% within six months of launch.
- Isodiol International, Inc.: In 2023, Isodiol launched a CBD-enhanced drink for post-exercise recovery. The beverage, featuring electrolytes and adaptogens, gained 27% market share among wellness drinkers in the U.S. The brand also recorded a 35% spike in sales from fitness centers and spas offering the product as part of recovery kits.
Report Coverage
The Hemp Source CBD Market report provides a comprehensive and data-rich analysis of the industry's current landscape, with a detailed breakdown of type-wise, application-wise, and region-wise trends. The report covers the performance of Hemp Source CBD across more than 20 countries, tracking over 55% of active product formulations in wound healing care, skincare, dietary supplements, and functional beverages. It analyzes more than 30 industry variables impacting production, distribution, regulation, and consumer adoption.
Approximately 48% of the companies covered in the report are focused on personal care and cosmetics, where CBD integration into wound healing care products and anti-inflammatory applications continues to rise. Another 29% of profiled players are innovators in nutraceuticals and food supplements. The report also tracks investments, with about 34% of the total capital inflow in the last two years directed toward sustainable hemp farming and extraction technology upgrades.
The coverage includes detailed insights into over 70 new product launches, 45 regional expansion initiatives, and 38 regulatory approvals, all of which contribute to mapping the market trajectory. Additionally, the report provides benchmarking data for 15 top-performing brands, along with performance metrics such as consumer adoption rate (52%), product reorder frequency (31%), and brand loyalty rate (43%) within the wound healing care segment. This full-spectrum coverage enables stakeholders to make informed decisions backed by quantitative and qualitative intelligence.
| Report Coverage | Report Details |
|---|---|
|
By Applications Covered |
Personal Care and Cosmetics,Food and Beverages,Nutraceuticals,Others |
|
By Type Covered |
Hemp-derived CBD Distillate,Hemp-derived CBD Isolate,Hemp-derived CBD Terpenes |
|
No. of Pages Covered |
102 |
|
Forecast Period Covered |
2025 to 2033 |
|
Growth Rate Covered |
CAGR of 0.14% during the forecast period |
|
Value Projection Covered |
USD 143.20 Billion by 2033 |
|
Historical Data Available for |
2020 to 2023 |
|
Region Covered |
North America, Europe, Asia-Pacific, South America, Middle East, Africa |
|
Countries Covered |
U.S. ,Canada, Germany,U.K.,France, Japan , China , India, South Africa , Brazil |
Download FREE Sample Report